News

Results of a second phase study showed patients with category 3 dry age-related macular degeneration (AMD) can achieve increased and sustained visual acuity levels with administration of correct carotenoids, vitamins and minerals.

Consequences of reform

J.C. Noreika, MD, MBA, submitted a letter to Sen. Sherrod Brown (D-OH), outlining nine possible unintended consequences to health-care reform.

Results from a series of bench studies evaluating a new 25+-gauge vitrectomy proble and trocar system highlight the benefits and improved performance of this technology compared with previous instrumentation for microincision vitrectomy surgery.

Data analyses collected in a phase III clinical trial show a strong benefit of intravitreal ranibizumab for clearing macular edema and rehabilitating vision in patients who have suffered a branch retinal vein occlusion.

New data from phase III clinical trials of dexamethasone 0.7 mg intravitreal implant reaffirm that this novel pharmacotherapeutic intervention is well-tolerated and effectively improves vision in patients with macular edema secondary to a branch or central retinal vein occlusion.

A new device for at-home monitoring of age-related macular degeneration is a promising tool for early detection of choroidal neovascularization.

A new 577-nm solid-state laser allows retinal specialists to harness the benefits of yellow light for laser photocoagulation while providing a number of additional advantages.

Twice-daily dosing of bepostastine besilate ophthalmic solution 1.5% was found to be safe, with minimal adverse events, in a randomized, double-masked, 6-week safety study including two groups of healthy pediatric patients.

An interactive computer-based surgical teaching program is being developed as a training tool to provide users with the cognitive aspects of learning that are fundamental for developing expertise.

The incidence of diabetes, which had been increasing by leaps and bounds along with complications of the disease, has been showing signs of stabilizing and decreasing as the result of intensive management of the disease.

A dermatologic treatment for patients who have rosacea and other skin conditions increasingly will find use as an ophthalmologic treatment for patients who have dry eye as a result of meibomian gland dysfunction and blepharitis.